Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder

NCT07253207 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

392

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: Levomilnacipran Hydrochloride Extended-Release Capsules
DRUG: Duloxetine Hydrochloride Enteric Capsules

Sponsor

Zhejiang Huahai Pharmaceutical Co., Ltd.